These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2984607)

  • 1. Functional alteration of opioid receptor subtypes in the mice exhibited conditioned suppression in motility.
    Kameyama T; Nabeshima T; Kamei H; Matsuno K
    Neurosci Lett; 1985 Feb; 53(3):263-6. PubMed ID: 2984607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditioned suppression and opioid kappa receptor in mice.
    Nabeshima T; Kamei H; Matsuno K; Kameyama T
    J Pharmacobiodyn; 1986 Jan; 9(1):74-80. PubMed ID: 3012059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role played by sigma receptors in the conditioned suppression of motility in mice.
    Nabeshima T; Kamei H; Kameyama T
    Psychopharmacology (Berl); 1988; 94(4):515-20. PubMed ID: 2836876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences of alteration in opioid systems induced by conditioned suppression and electric footshock in mice.
    Kameyama T; Nabeshima T; Yamada K
    Pharmacol Biochem Behav; 1985 Feb; 22(2):249-54. PubMed ID: 2984703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (+)-[3H]SKF 10,047, (+)-[3H]ethylketocyclazocine, mu, kappa, delta and phencyclidine binding sites in guinea pig brain membranes.
    Tam SW
    Eur J Pharmacol; 1985 Feb; 109(1):33-41. PubMed ID: 2986989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous ligands for sigma opioid receptors in the brain ("sigmaphin"): evidence from binding assays.
    Su TP; Weissman AD; Yeh SY
    Life Sci; 1986 Jun; 38(24):2199-210. PubMed ID: 3012236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid kappa receptors correlate with the development of conditioned suppression of motility in mice.
    Nabeshima T; Kamei H; Kameyama T
    Eur J Pharmacol; 1988 Jul; 152(1-2):129-33. PubMed ID: 2850197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of multiple kappa-opioid receptors by selective and nonselective ligand binding in guinea pig spinal cord: resolution of high and low affinity states of the kappa 2 receptors by a computerized model-fitting technique.
    Tiberi M; Magnan J
    Mol Pharmacol; 1990 May; 37(5):694-703. PubMed ID: 2160061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role played by dopamine and opioid neuronal systems in stress-induced motor suppression (conditioned suppression of motility) in mice.
    Nabeshima T; Katoh A; Hiramatsu M; Kameyama T
    Brain Res; 1986 Nov; 398(2):354-60. PubMed ID: 3801908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of different opioid receptor subtypes in electric shock-induced analgesia and motor suppression in the rat.
    Nabeshima T; Matsuno K; Kameyama T
    Eur J Pharmacol; 1985 Aug; 114(2):197-207. PubMed ID: 2995079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
    De Souza EB; Schmidt WK; Kuhar MJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of the heterogeneity of the kappa-opioid receptors in guinea-pig cerebellum using selective and nonselective drugs.
    Tiberi M; Magnan J
    Eur J Pharmacol; 1990 Jun; 188(6):379-89. PubMed ID: 2164939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
    James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
    Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type.
    Garzón J; Sánchez-Blázquez P; Lee NM
    J Pharmacol Exp Ther; 1984 Oct; 231(1):33-7. PubMed ID: 6092603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of opiate agonists on the conditioned suppression in motility of mice.
    Nabeshima T; Yamada K; Kameyama T
    Neurosci Lett; 1983 Sep; 39(3):301-6. PubMed ID: 6355913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical characterization and regional quantification of mu, delta and kappa opioid binding sites in rat spinal cord.
    Stevens CW; Lacey CB; Miller KE; Elde RP; Seybold VS
    Brain Res; 1991 May; 550(1):77-85. PubMed ID: 1653636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
    Tam SW; Liu-Chen LY
    J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple opioid receptor systems in brain and spinal cord: Part I.
    Yaksh TL
    Eur J Anaesthesiol; 1984 Jun; 1(2):171-99. PubMed ID: 6152613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CI-977, a novel and selective agonist for the kappa-opioid receptor.
    Hunter JC; Leighton GE; Meecham KG; Boyle SJ; Horwell DC; Rees DC; Hughes J
    Br J Pharmacol; 1990 Sep; 101(1):183-9. PubMed ID: 2178014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult and developing human cerebella exhibit different profiles of opioid binding sites.
    Zagon IS; Gibo DM; McLaughlin PJ
    Brain Res; 1990 Jul; 523(1):62-8. PubMed ID: 2169964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.